(Q37796009)

23 August 2017

Genetic mouse models of Parkinson's disease The state of the art. (English)

1 reference

Marie-Françoise Chesselet

23 August 2017

1 reference

series ordinal

2

object named as

Marie-Françoise Chesselet

1 reference

23 August 2017

Iddo Magen

1

1 reference

23 August 2017

1 January 2010

1 reference

Progress in Brain Research

23 August 2017

1 reference

23 August 2017

184

1 reference

23 August 2017

53-87

1 reference

Paraquat and iron exposure as possible synergistic environmental risk factors in Parkinson's disease

23 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Impaired learning and memory in Pitx3 deficient aphakia mice: a genetic model for striatum-dependent cognitive symptoms in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Role of locus coeruleus in attention and behavioral flexibility

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Morphological alterations of the synapses in the locus coeruleus in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Small molecule oxidation products trigger disease-associated protein misfolding.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Staging of brain pathology related to sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Exacerbated synucleinopathy in mice expressing A53T SNCA on a Snca null background

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Alpha-synuclein locus duplication as a cause of familial Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Age-dependent motor deficits and dopaminergic dysfunction in DJ-1 null mice

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Proteasome dysfunction in aged human alpha-synuclein transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Synthetic filaments assembled from C-terminally truncated alpha-synuclein.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Conditional transgenic mice expressing C-terminally truncated human alpha-synuclein (alphaSyn119) exhibit reduced striatal dopamine without loss of nigrostriatal pathway dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Alpha-synuclein and transgenic mouse models

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Behavioral and histopathological consequences of paraquat intoxication in mice: effects of alpha-synuclein over-expression

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype alpha-synuclein

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Olfactory deficits in mice overexpressing human wildtype alpha-synuclein

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Parkin deficiency increases vulnerability to inflammation-related nigral degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Tau phosphorylation increases in symptomatic mice overexpressing A30P alpha-synuclein

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Age-dependent cognitive decline and amygdala pathology in alpha-synuclein transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

alpha-Synuclein is phosphorylated in synucleinopathy lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Alpha-synuclein transgenic mice exhibit reduced anxiety-like behaviour.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Gain-of-function haplotypes in the vesicular monoamine transporter promoter are protective for Parkinson disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Motor dysfunction and gliosis with preserved dopaminergic markers in human alpha-synuclein A30P transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Role of alpha-synuclein in synaptic glutamate release

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Aging and alpha-synuclein affect synaptic plasticity in the dentate gyrus.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Transgenic rodent models of Parkinson’s disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

3,4-dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Vesicular monoamine transporter 2 and dopamine transporter are molecular targets of Pitx3 in the ventral midbrain dopamine neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Motor impairment and aberrant production of neurochemicals in human alpha-synuclein A30P+A53T transgenic mice with alpha-synuclein pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Absence of nigral degeneration in aged parkin/DJ-1/PINK1 triple knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Lovastatin ameliorates alpha-synuclein accumulation and oxidation in transgenic mouse models of alpha-synucleinopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Conformational behavior of human alpha-synuclein is modulated by familial Parkinson's disease point mutations A30P and A53T.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Forebrain overexpression of alpha-synuclein leads to early postnatal hippocampal neuron loss and synaptic disruption

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: implications for pathogenesis of Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

G protein-coupled receptor kinase 5, overexpressed in the alpha-synuclein up-regulation model of Parkinson's disease, regulates bcl-2 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

α-Synuclein Overexpression Protects against Paraquat-Induced Neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Enhanced sensitivity to group II mGlu receptor activation at corticostriatal synapses in mice lacking the familial parkinsonism-linked genes PINK1 or Parkin.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Changes in adult olfactory bulb neurogenesis in mice expressing the A30P mutant form of alpha-synuclein

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Influence of different promoters on the expression pattern of mutated human alpha-synuclein in transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Wild-type and mutant alpha-synuclein induce a multi-component gene expression profile consistent with shared pathophysiology in different transgenic mouse models of PD.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Role of alpha-synuclein carboxy-terminus on fibril formation in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Increased sensitivity to MPTP in human alpha-synuclein A30P transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Pesticide exposure exacerbates alpha-synucleinopathy in an A53T transgenic mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Neurodegeneration and motor dysfunction in a conditional model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Behavioural and neurochemical response of alpha-synuclein A30P transgenic mice to the effects of L-DOPA.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

A chemical chaperone, sodium 4-phenylbutyric acid, attenuates the pathogenic potency in human alpha-synuclein A30P + A53T transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Mitochondrial dysfunction and oxidative damage in parkin-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Parkinson disease: not just a movement disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Genomewide association study for susceptibility genes contributing to familial Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Nigrostriatal dysfunction in homozygous and heterozygous parkin gene carriers: an 18F-dopa PET progression study

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Parkin-deficient mice are not a robust model of parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Proteomic analysis of parkin knockout mice: alterations in energy metabolism, protein handling and synaptic function

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice--a model of familial Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Dopamine transporter genetic variants and pesticides in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

A Drosophila model of mutant human parkin-induced toxicity demonstrates selective loss of dopaminergic neurons and dependence on cellular dopamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Altered Fatty Acid Composition of Dopaminergic Neurons Expressing α-Synuclein and Human Brains with α-Synucleinopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Mouse models of alpha-synucleinopathy and Lewy pathology.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Mono- and double-mutant mouse models of Parkinson's disease display severe mitochondrial damage

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Mutant alpha-synuclein overexpression mediates early proinflammatory activity

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Synuclein activates microglia in a model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Risk factors for dopaminergic neuron loss in human alpha-synuclein transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Locomotor hyperactivity and alterations in dopamine neurotransmission are associated with overexpression of A53T mutant human alpha-synuclein in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Neuropathology in mice expressing human alpha-synuclein

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Inclusion body formation and neurodegeneration are parkin independent in a mouse model of alpha-synucleinopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Loss of locus coeruleus neurons and reduced startle in parkin null mice

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Inflammatory cytokine gene polymorphisms and increased risk of Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Selective loss of nigral dopamine neurons induced by overexpression of truncated human alpha-synuclein in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Dopamine receptor agonists reverse behavioral abnormalities of alpha-synuclein transgenic mouse, a new model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Pael-R transgenic mice crossed with parkin deficient mice displayed progressive and selective catecholaminergic neuronal loss

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Alterations in corticostriatal synaptic plasticity in mice overexpressing human alpha-synuclein

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Human Wild-Type α-Synuclein Impairs Neurogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Mutant alpha-synuclein exacerbates age-related decrease of neurogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Transcriptional dysregulation in a transgenic model of Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Abnormal compartmentalization of norepinephrine in mouse dentate gyrus in alpha-synuclein knockout and A30P transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Locomotor activity and evoked dopamine release are reduced in mice overexpressing A30P-mutated human alpha-synuclein

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Increased dopaminergic neuron sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in transgenic mice expressing mutant A53T alpha-synuclein

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Transgenic mice overexpressing tyrosine-to-cysteine mutant human alpha-synuclein: a progressive neurodegenerative model of diffuse Lewy body disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

Non-motor behavioural impairments in parkin-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2810%2984004-X

7 January 2021

10.1016/S0079-6123(10)84004-X

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

20887870